Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ralaniten

Ralaniten (EPI-506) is a novel small-molecule inhibitor of androgen receptor (AR) N-terminal domain inhibitor for the treatment of advanced prostate cancer.

Product Specifications

CAS Number

1203490-23-6

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

394.89

Molecular Formula

C21H27ClO5

Notes

Research use only, not for human use.

Receptor

Estrogen Receptor/ERR

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

FGFRL1, NT (FGFRL1, FGFR5, FHFR, Fibroblast growth factor receptor-like 1, FGF homologous factor receptor, FGFR-like protein, Fibroblast growth factor receptor 5)
035644 200 µL

FGFRL1, NT (FGFRL1, FGFR5, FHFR, Fibroblast growth factor receptor-like 1, FGF homologous factor receptor, FGFR-like protein, Fibroblast growth factor receptor 5)

Sign In for Pricing
View Details
Recombinant Influenza A virus Non-structural protein 1 (NS)
CSB-EP391362ILO-01 20 µg

Recombinant Influenza A virus Non-structural protein 1 (NS)

Sign In for Pricing
View Details
Recombinant Influenza A virus Non-structural protein 1 (NS)
CSB-EP391362ILO-02 100 µg

Recombinant Influenza A virus Non-structural protein 1 (NS)

Sign In for Pricing
View Details
Recombinant Influenza A virus Non-structural protein 1 (NS)
CSB-EP391362ILO-03 1 mg

Recombinant Influenza A virus Non-structural protein 1 (NS)

Sign In for Pricing
View Details
Rabbit Anti-Rat Atrial Natriuretic Peptide (ANP) Polyclonal Antibody
VD3N380 1 Each

Rabbit Anti-Rat Atrial Natriuretic Peptide (ANP) Polyclonal Antibody

Sign In for Pricing
View Details
GUCY2D (Guanylate Cyclase 2D, Membrane (Retina-Specific), CORD5, CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, RETGC-1, ROS-GC1, retGC) (AP) discontinued
246871-AP 100 µL

GUCY2D (Guanylate Cyclase 2D, Membrane (Retina-Specific), CORD5, CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, RETGC-1, ROS-GC1, retGC) (AP) discontinued

Sign In for Pricing
View Details